Ann: Complete Regression of TNBC Tumours and Protective Immunity, page-156

I think Mike is out, lots of newbies on this thread now. 46m through at 17 today, bidding 16. It always amazes me that hotcopper almost never has a neg view, but here's one. The previous cap raise was at 14 but half of it went back to the investor for 'services rendered' so my take is that the raising was really at 7. (Raising previous to recent 22 with far out priced options attached). Shares on issue 5.5 billion so, get a grip on that! Other companies with same research, but ivx just has their own formula, that's all. Even if ivx goes back to 3c with 5.5 billion on issue it would be worth blue chip capitalisation value, all for rights to distrib in australia? Danger, Will Robinson..